X4 Pharmaceuticals, Inc.
ACYCLIC CXCR4 INHIBITORS AND USES THEREOF
Last updated:
Abstract:
The present invention relates to compounds and methods useful for modulation, e.g. inhibition, of C-X-C receptor type 4 (CXCR4). The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using the compositions in the treatment of various disorders.
Status:
Application
Type:
Utility
Filling date:
18 Dec 2018
Issue date:
14 Jan 2021